Edition:
United States

Recipharm AB (publ) (RECIb.ST)

RECIb.ST on Stockholm Stock Exchange

134.40SEK
20 Jul 2018
Change (% chg)

-0.60kr (-0.44%)
Prev Close
135.00kr
Open
134.80kr
Day's High
136.20kr
Day's Low
133.80kr
Volume
49,328
Avg. Vol
151,959
52-wk High
138.00kr
52-wk Low
82.80kr

Chart for

About

Recipharm publ AB is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). It is divided in two business areas: Manufacturing Services, supplying a range of pharmaceutical products in different dosage forms, such as solid dose, semi solids, beta-lactams, hormones, dry... (more)

Overall

Beta: 1.64
Market Cap(Mil.): kr7,044.70
Shares Outstanding(Mil.): 52.18
Dividend: --
Yield (%): --

Financials

  RECIb.ST Industry Sector
P/E (TTM): -- 29.12 33.34
EPS (TTM): -1.98 -- --
ROI: -1.16 13.60 13.18
ROE: -2.60 15.30 15.09

BRIEF-Recipharm Q1 EBITDA Up At SEK 250 Million

* Q1 NET SALES SEK 1.51 BILLION VERSUS SEK 1.33 BILLION YEAR AGO

Apr 27 2018

BRIEF-Recipharm Signs Licensing Agreement with Altus Formulation

* RECIPHARM AND ALTUS FORMULATION COLLABORATE TO OFFER NOVEL DRUG DELIVERY TECHNOLOGIES FOR VALUE ADDED MEDICINES

Mar 05 2018

BRIEF-Recipharm CFO Resigns

* ‍HENRIK STENQVIST WILL SERVE AS CFO UNTIL LATER IN SPRING.​

Feb 26 2018

BRIEF-Recipharm Q4 EBITDA At SEK 226 Million

* Q4 NET SALES SEK 1.40 BILLION VERSUS SEK 1.33 BILLION YEAR AGO

Feb 22 2018

Earnings vs. Estimates